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ABSTRACT 
Background: Avoidable hospital mortality is often attributable to inadequate patient vital 
signs monitoring, and failure to recognise or respond to clinical deterioration. The processes 
involved with vital sign collection and charting; their integration, interpretation and analysis; 
and the delivery of decision support regarding subsequent clinical care are subject to potential 
error and/or failure.  
 
Objective: To determine whether introducing an electronic physiological surveillance system 
(EPSS), specifically designed to improve the collection and clinical use of vital signs data, 
reduced hospital mortality. 
 
Methods: A pragmatic, retrospective, observational study of seasonally adjusted in-hospital 
mortality rates in three main hospital specialties was undertaken before, during and after the 
sequential deployment and ongoing use of a hospital-wide EPSS in two large unconnected 
acute general hospitals in England. The EPSS, which uses wireless handheld computing 
devices replaced a paper-based vital sign charting and clinical escalation system. 
 
Results: During EPSS implementation, crude mortality fell from a baseline of 7.75% 
(2168/27959) to 6.42% (1904/29676) in one hospital [estimated 397 fewer deaths], and from 
7.57% (1648/21771) to 6.15% (1614/26241) at the second [estimated 372 fewer deaths]. At 
both hospitals, multi-year statistical process control analyses revealed abrupt and sustained 
mortality reductions, coincident with the deployment and increasing use of the system. The 
cumulative total of excess deaths reduced in all specialties with increasing use of the system 
across the hospital.  
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Conclusions: The use of technology specifically designed to improve the accuracy, 
reliability and availability of patients’ vital signs and early warning scores, and thereby the 
recognition of and response to patient deterioration, is associated with reduced mortality in 
this study. 
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BACKGROUND 
Failure to recognise and respond to patient deterioration in hospital is considered a major 
cause of avoidable morbidity and mortality.1-5 One of the initial steps in identifying 
deterioration involves the measurement of vital signs.6,7 For most patients on general wards, 
routine vital signs measurement is undertaken manually and intermittently, with or without 
automated machines, at intervals based on the patients’ severity of illness.4,7-9 Vital signs data 
are generally recorded on paper charts placed at the end of the patients’ beds or in their 
rooms. These processes are subject to potential error and/or failure, such as inadequate 
monitoring frequency;1-3,5,10-12 incomplete data;1,10,13 inaccurate early warning score (EWS) 
calculations;14-17 and poor legibility and interpretability of charts.18,19 ; all of which have been 
implicated in the failure to recognize, or respond to, patient deterioration.1-3,5 
 
We postulated that an appropriately designed clinical information technology (IT) system 
could improve the reliability of collecting and charting vital signs; their integration, 
interpretation and analysis; and the delivery of decision support regarding subsequent clinical 
care. Therefore, staff from Queen Alexandra Hospital (QAH), Portsmouth and The Learning 
Clinic Ltd. (TLC), London used existing knowledge, research data and National Institute for 
Health and Care Excellence (NICE) recommendations4 to design an electronic physiological 
surveillance system (EPSS)20 - VitalPAC - with the specific objectives of improving the 
accuracy, reliability, availability and clinical impact of patients’ vital signs datasets and EWS 
records. The EPSS was subsequently deployed across QAH and a second, acute general 
hospital in England - University Hospital Coventry (UHC)  - in phased rollouts on each site. 
We report an observational study of the temporal changes in hospital mortality associated 
with the implementation of the EPSS in the two hospitals. 
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 METHOD 
Ethical Committee Approval 
The Isle of Wight, Portsmouth and South East Hampshire Research Ethics Committee (study 
ref. 08/02/1394) approved the study. 
 
The electronic physiological surveillance system (EPSS)20 
The EPSS - VitalPAC - is specially designed software that prompts nurses to record a 
complete set of vital signs at the patient’s bedside at appropriate intervals on handheld 
computing devices. For each vital sign, the EPSS takes the measured physiological value and 
the locally embedded aggregate weighted early warning scoring system (which were different 
at QAH and UHC) to assign a weighting, based on the derangement of the physiological 
value from an arbitrarily agreed ‘normal’ range. The EPSS automatically and accurately 
calculates the patient’s EWS and provides instant bedside decision support on a graded basis 
according to the EWS value to staff.20 This includes when the next set of vital signs is due; 
whether care should be escalated to senior staff (e.g., rapid response team (RRT)21); and the 
required speed of any response. These messages are delivered directly to the handheld device 
in use by the staff at the bedside via standard colour-coded screen messages. The devices 
communicate wirelessly with the hospital’s computer system. They routinely record the vital 
signs data in a clear and easily interpreted electronic record that can be viewed anywhere in 
the hospital by staff with the appropriate access rights, using mobile or fixed computers 
linked to the hospital intranet.20 The EPSS also pulls in data from the hospital patient 
administration system, laboratory results, and other clinical information stored electronically. 
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Setting and Intervention:  
QAH and UHC are large (>1000 bed) acute general hospitals approximately 240km apart in 
England. An acute care educational programme for ward staff,22 the use of a paper-based 
EWS system23 and a RRT21 were all well established in each hospital, many years before the 
implementation of the EPSS. EPSS implementation at the hospitals differed in several 
aspects. Vital signs charts were viewable on wireless PC tablets and desktop PCs at QAH, but 
only on desktop PCs on wards at UHC. The EPSS software used the locally embedded EWS 
(which were different at QAH and UHC).  The EPSS was implemented sequentially in wards, 
although the speed and order differed at each hospital. As EPSS implementation proceeded to 
each ward, vital signs charting there became electronic and paper-based charting ceased.  
 
QAH 
Following a pilot period of 14 months during which the system was developed, QAH 
deployed the EPSS to the Acute Medicine Unit (AMU) in May 2006 and then the 
Surgical Assessment Unit (SAU) in January 2007. The EPSS was implemented on a 
single medical ward in June 2008 and three high-risk medical wards (cardiology, 
pulmonology and elderly care) in February 2009. Further deployment across the 
hospital was delayed until after the opening of a new hospital wing on 15th June 2009. 
Thereafter, hospital-wide rollout continued in the following order - medical; surgical; 
trauma and orthopaedic (T&O) wards - and was completed in December 2009. During 
the implementation process (February - December 2009), a team of one whole time 
equivalent (WTE) nurse, 0.25 WTE trainers provided by TLC, and 0.2 WTE physicians 
facilitated user training at QAH. After deployment, the nurse was available for post-
deployment issues such training, support, and operational policies for a further seven 
months. 
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UHC 
UHC conducted a single-ward pilot (May 2007 - February 2008) before rolling out the 
EPSS on all adult inpatient wards, in no particular specialty order, from March 2008. 
Deployment to the UHC emergency admissions unit (EAU), which admits acute 
medical emergencies, was completed in April 2009. The remaining surgical and T&O 
wards implemented the EPSS late in 2009. A team of 6 WTE nurses provided user 
training and support at UHC for a total of 6 months.  
 
The EPSS was not implemented in the maternity wards, paediatric units and intensive care 
units at either site.  
 
Data collection and sources of data:  
We collected two key items of data: a measure of EPSS implementation and hospital 
mortality. 
Measure of EPSS implementation 
We used the number of observations sets recorded per month to track the 
implementation of the EPSS. 
 
Hospital mortality 
The UK National Health Service (NHS) uses outcome data from 56 diagnosis groups 
(which account for 83% of inpatient deaths in England) to monitor and compare 
hospital performance.24 We analysed monthly observed mortality data from these 
diagnosis groups at QAH and UHC from July 2004 to June 2011. Admission data were 
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obtained for both hospitals by means of the ‘Real Time Monitoring’ tool (Dr Foster 
Intelligence, London).25 Our numerator is the count of deaths at the point of discharge. 
Day case spells (inpatient admissions where the intention was to treat and discharge on 
the same day, and this was achieved) were excluded from the denominator; day case 
deaths were retained in the numerator. 
 
The overall pre-intervention average crude mortality rate for the aforementioned 
collection of 56 diagnosis groups was used to calculate the expected deaths in the 
intervention and post-intervention years based on the number of admissions with the 
relevant diagnoses in those years.  Avoided deaths are equal to the difference between 
the observed and expected deaths in each calendar year. 
 
Data analysis: 
Crude monthly and annual mortality rates were calculated with 95% confidence intervals 
based on the normal approximation for binomial proportions. Statistical analyses were 
performed using Microsoft Excel 2007 (Microsoft Corporation, USA), and Stata/IC 11.1 
(StataCorp LP, USA). The mortality data were used in two ways: 
 
Method 1: Multi-year trend analysis 
Seasonally adjusted, monthly, statistical process control charts26 of hospital mortality 
were produced for both hospitals from July 2004 to July 2011 inclusive and were 
studied for a persistent change in the run of data points around the mean (i.e., evidence 
of special cause change). Upper (ucl) and lower control limits (lcl) were, as usual, set at 
3 standard deviations from the mean. Seasonal variation was removed to emphasise the 
underlying trend and help identify any special cause change. Adjusting for seasonality 
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required the calculation of monthly factors from the seven years of data by means of a 
weighted 13-month moving average used as a symmetric filter. This yielded six years 
of monthly factors (since the first and last six months do not meet the centering 
requirement), which were used to remove the seasonal variation in deaths. Using a 
similar process, monthly admissions data were seasonally adjusted to derive a 
seasonally adjusted mortality rate (SA-MR) for each hospital.  
 
Method 2: Analysis of deaths occurring in specialties 
The seasonally adjusted deaths from July 2004 to July 2011 for Medicine, Surgery, and 
T&O were analysed using a CUSUM method,27 plotting the cumulative monthly 
difference between expected deaths and the seasonally adjusted observed deaths.  For 
each month, and each specialty group, expected deaths were calculated as the product 
of the mean mortality rate for the whole period over which the CUSUM is plotted (i.e., 
July 2004-July 2011) and the seasonally adjusted admissions for the month. “Medicine” 
included Cardiology, Diabetic Medicine, Endocrinology, Gastroenterology, General 
Medicine, Geriatric Medicine, Infectious Diseases, Nephrology, Neurology, 
Respiratory Medicine, Rheumatology, Clinical Haematology and Oncology. “Surgery” 
included General, Breast, Cardiothoracic, Colorectal, Hepatobiliary & Pancreatic 
Surgery, Neurosurgery, Plastics, Renal Surgery, Transplantation, Upper 
Gastrointestinal, Urology, and Vascular Surgery. Control limits were added using the 
method described by Grunkemeier et al.28 
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RESULTS 
During implementation of EPSS across QAH, crude mortality fell from 7.75% (2168/27959) 
at baseline (2004) to 6.42% (1904/29676) after implementation (2010) (p <0.0001), with an 
estimated 397 fewer deaths (Table 1). Similarly, at UHC, crude mortality fell from 7.57% 
(1648/21771) at baseline (2006) to 6.15% (1614/26241) (2010) (p<0.0001) at UHC 
[estimated 372 fewer deaths] (Table 1). In both hospitals, SA-MR fell markedly and 
remained low in both hospitals within a short time of electronic physiological surveillance 
being implemented for the whole hospital journey (i.e., AMU plus one or more medical 
wards at QAH; EAU plus medical wards at UHC) (Figures 1a and 1b) for medical patients. 
Before these points (QAH, June 2008: UHC, April 2009), seasonally adjusted mortality was 
predominantly above the seven year mean  (QAH 30/47 [63.8%] months; UHC 45/57 
[78.9%]), whereas afterwards, it was seldom so  (QAH 4/37 [10.8%] months; UHC 2/27 
[7.4%]). In both hospitals, there was also less variation in SA-MR. Figures 1a and 1b also 
show special cause variation indicated by 28 successive SA-MR observations below the 
centerline at QAH, and two runs of 18 and 7 points at UHC. 
 
Table 1. Annual in-patient mortality for Queen Alexandra Hospital (QAH) (2004-2010) and 
University Hospital Coventry (UHC) (2006-2010). 
 
 QAH 
Baselin
e  After 
Calendar year 2004 2005 2006 2007 2008 2009 2010 
Average age of adult 
inpatients 
62.6 
(62.4-
62.9) 
63.2 
(62.9-
63.1) 
63.1 
(62.8-
63.3) 
63.7 
(63.5-
64.0) 
64.2 
(64.0-
64.5) 
64.5 
(64.2-
64.7) 
66.3 
(64.3-
64.7) 
All spells 33983 34919 36367 37963 40622 39553 38694 
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Spells excluding day 
cases 
27959 28575 28910 29364 30539 30427 29676 
Observed deaths (O) 2168 2172 2055 2053 2132 1996 1904 
Crude mortality rate 
(MR)a 
7.75% 7.60% 7.11% 6.99% 6.98% 6.56% 6.42% 
% change in crude MR  -1.98% -8.33% -9.84% -9.97% -
15.40% 
-
17.26% 
Relative risk (95% CI) 
cf. baseline year 
 0.98 
(0.93-
1.04) 
0.92 
(0.87-
0.97) 
0.90 
(0.85-
0.96) 
0.90 
(0.85-
0.95) 
0.85 
(0.80-
0.90) 
0.83 
(0.78-
0.88) 
p-value for relative risk  
cf. baseline year 
 0.497 0.003 <0.001 <0.001 <0.001 <0.001 
         
Expected deathsb (E)  2216 2242 2277 2368 2359 2301 
Deaths avoided (E-O)  44 187 224 236 363 397 
        
UHC   Baselin
e 
 After 
Calendar year   2006 2007 2008 2009 2010 
Average age of adult 
inpatients  
  63.0 
(62.7-
63.3) 
63.7 
(63.4-
64.0) 
64.0 
(63.8-
64.3) 
64.3 
(64.1-
64.6) 
64.9 
(64.6-
65.1) 
All spells   30878 31990 36282 39496 40483 
Spells excluding day 
cases 
  21771 21840 23270 25585 26241 
Observed deaths (O)   1648 1688 1725 1675 1614 
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Crude mortality rate 
(MR)a 
  7.57% 7.73% 7.41% 6.55% 6.15% 
% change in crude MR    2.10% -2.07% -
13.51% 
-
18.75% 
Relative risk (95% CI) 
cf. baseline year 
   1.02 
(0.95-
1.09) 
0.98   
(0.92-
1.05) 
0.87 
(0.82-
0.93) 
0.82 
(0.77-
0.88) 
p-value for relative risk  
cf. baseline year 
   0.565 0.568 <0.001 <0.001 
        
Expected deathsb (E)    1653 1761 1937 1986 
Deaths avoided (E-O)    -35 36 262 372 
a Observed deaths for 56 diagnoses accounting for 83% of inpatient deaths in England were 
used to calculate the annual crude mortality rate.  
b The pre-intervention crude mortality rate was used to calculate the expected deaths in 
subsequent years based on the number of admissions with any of the 56 diagnoses in those 
years.  
 
During the EPSS implementation period, average patient age rose from 63.9 years (May 
2005) to 67.0 years (June 2011), and percentage of emergency admissions from 79.5% (May 
2005) to 86.2% (June 2011) at QAH (Figure 2a). At UHC, there was a slight rise in average 
patient age (61.5 years, May 2007; 62.1 years, June 2011), and a slight fall in the percentage 
of emergency admissions (53.4%, May 2005; 50.8%, June 2011) (Figure 2b). 
 
For the CUSUM charts (Figures 3a-3c, QAH; Figures 4a-4c, UHC), a downward slope 
corresponds to more deaths than expected and an upward slope corresponds to fewer deaths 
than expected. At QAH, all three specialties show a steadily rising total of excess deaths from 
July 2004. However, in May 2006, coincident with deployment of EPSS in AMU, the rate of 
rise slowed and plateaued (Figure 3a) before falling (Feb 2009 onwards) with the hospital-
 12 
wide rollout. A more abrupt reversal was seen following EPSS implementation in SAU in 
January 2007 (Figure 3b). The reduction in mortality in T&O followed immediately after full 
implementation there (Figure 3c).  In all three specialties, increasing use of the EPSS across 
the hospital was associated with a decreasing cumulative total of excess deaths (Figures 3a-
3c).  
 
At UHC, there was also a rising total of excess deaths from July 2004 for all three specialties 
(Figures 4a-4c). For Medicine, the mortality plateaued following the first use of the EPSS, 
but did not begin to fall until the EPSS was also implemented in the EAU (Figure 4a). The 
increasing use of the EPSS in the surgical, and T&O wards from April 2008 onwards was 
again associated with reducing mortality, although the reduction was delayed in the T&O 
wards (Figures 4b and 4c).  
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DISCUSSION  
This study provides evidence that the implementation of an electronic physiological 
surveillance system specifically designed to increase the reliability of the collection, 
documentation and display of vital signs in hospital is associated with a significant reduction 
in hospital mortality.  Whilst impossible to prove a direct cause-and-effect relationship 
between the two, the development of the EPSS in one hospital, its subsequent implementation 
in a second approximately 240km away and the almost identical results from the two sites 
support our view that this is a significant finding. Importantly, there are temporal 
relationships between mortality reduction, and the events at hospital and specialty level in 
both hospitals. Together, the results appear to suggest that the intervention has both 
reproducibility and generalisability, based on a plausible direct relationship.29 
 
The results suggest a strong relationship between increasing use of the EPSS and the reduced 
mortality in all three specialties at each hospital. The different timing of the reduction at the 
two hospitals also appears to reflect the different deployment schedules in all specialty 
groups except T&O at UHC, where a lag of almost 12 months is seen. We are unable to offer 
a definite explanation for this latter finding, but it may be due to issues that are not addressed 
directly by the EPSS and which have been reported in other hospitals, e.g., staff reluctance to 
call for help with deteriorating patients.30,31  
 
In both hospitals, most deaths occur in medical and elderly unscheduled admissions. For 
medical admissions at both hospitals, achieving surveillance for the whole patient journey 
appears to have been extremely important in reducing mortality (Figures 3a and 4a). This 
point was reached at QAH for some medical patients in June 2008 when the EPSS was 
extended beyond the AMU to a single medical ward (a stroke ward). Any impact on mortality 
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in this ward was not visible in the hospital-wide SA-MR, however, the effect of the 
subsequent implementation of the EPSS on three high-risk medical wards in February 2009 is 
clearly apparent (Figure 3a). At UHC, although the EPSS was deployed on the medical wards 
early on, it was only deployed in the EAU in April 2009. The reduction in mortality occurred 
almost instantaneously thereafter (Figure 4a). In both hospitals, SA-MR fell markedly and 
remained low in both hospitals within a short time of electronic physiological surveillance 
being implemented for the whole hospital journey (i.e., AMU plus one or more medical 
wards at QAH; EAU plus medical wards at UHC) (Figures 1a and 1b) for medical patients. 
Before these points (QAH, June 2008: UHC, April 2009), seasonally adjusted mortality was 
predominantly above the mean (QAH 30/47 [63.8%] months; UHC 45/57 [78.9%]), whereas 
afterwards, it was seldom so  (QAH 4/37 [10.8%] months; UHC 2/27 [7.4%]). In both 
hospitals, there was also less variation in SA-MR. In figures 1a and 1b the SA-MR plot also 
shows special cause variation indicated by seven or more successive SA-MR observations 
below the centerline at both QAH and UHC, immediately following the point at which 
electronic vital signs surveillance in medical patients was complete for the whole patient 
journey for at least some patients. 
 
Of necessity, our research was a pragmatic observational study of real-world system 
deployments in two large hospitals. The difficulties of undertaking randomised controlled 
trials of technologies like ours - complexity, required duration and expense – have been 
previously discussed.32 The possibility of undertaking a stepped wedge design study33 was 
precluded by project management considerations; limited availability of project staff; 
contamination by movement of some patients between wards and specialties; and the 
complexity of creating matching cohorts for all inpatient specialties. 
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A weakness of our study is that we did not measure all cause mortality, but focused on that in 
the 56 diagnosis groups used by the UK NHS to monitor and compare hospital 
performance.24 However, there appears to be a very strong relationship between mortality in 
the 56 diagnosis groups studied and that for all causes.34 Our findings could also be 
accounted for by a changing admission case-mix during the study. However, age and 
percentage of emergency admissions increased at QAH during this period, and at UHC there 
was no real change in either. Certainly, there were no major case-mix changes synchronous 
with the observed reductions in mortality. No adjustment was made in our analyses for 
patients with Do-Not-Attempt-Cardiopulmonary-Resuscitation (DNACPR) decisions. 
 
It is also possible that a range of other changes in practice other than the EPSS (e.g., 
introducing care bundles35, altering nurse staffing levels36) could have caused or contributed 
to the year-on-year mortality reduction observed. However, to have this impact, it would have 
been necessary for these to have been introduced at very specific, and different, times in the 
given specialties at each of the hospitals. The opening of the new hospital wing at QAH (June 
15th 2009) occurred four months after the observed reduction in hospital mortality and could 
not explain the reduction in mortality seen at UHC. Finally, we could not identify any service 
reconfigurations, new processes, or increases in palliative care admissions or discharges to 
the local hospices, that might account for our results. 
 
It is also conceivable that the focus on the EPSS within the two hospitals produced a 
significant Hawthorne effect,37 which might account for some or all of the impact. However, 
the project teams’ focus on the EPSS deployment in each ward was usually limited to only 1-
2 weeks and it seems improbable that this would result in an impact lasting for over 2 years. 
The finding that mortality reductions for each specialty occurred at different times but on 
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each occasion coincided with the intervention in two separate hospitals also suggests that the 
EPSS itself was the critical agent of change. 
 
Why might the EPSS have reduced the hospital mortality? Before the introduction of the 
EPSS, staff in the study hospitals documented vital signs on paper charts; manually 
calculated EWS values; and followed escalation protocols written on paper. Given 
international evidence, it is likely that vital signs measurements were undertaken 
infrequently;1-3,5,10-12 datasets were incomplete;1,10,13 and there were errors in the calculation 
of EWS values.14-17 Using traditional paper-based vital signs charts limited their instant 
availability to their immediate vicinity, usually at the foot of the patient’s bed. 
 
We investigated an electronic solution to these problems, as IT systems are known to 
“…improve communication, make knowledge more readily accessible, require key pieces of 
information (such as the dose of a drug), assist with calculations, perform checks in real 
time, assist with monitoring, and provide decision support…”38 In developing the EPSS, we 
deliberately ‘designed out’ errors and known system failures to improve the reliability, 
efficiency and effectiveness of the vital signs collection, charting and escalation processes. 
We incorporated many of the principles outlined by Bates et al., e.g., integration of the EPSS 
in the user’s workflow; fast delivery of decision support; anticipation of the user’s needs; 
ensuring user acceptability by incorporating user feedback during the pilot phases; use of 
simple input screens; asking for data only when it was required; and enabling tracking of the 
responses to the decision support.39 
 
The EPSS requires the entry of a full vital signs dataset at each routine observation. Data 
from both study sites show that ~98% of all vital signs datasets recorded by the EPSS are 
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complete. It then uses a graded response strategy recommended by NICE4 to automatically 
determine the timing of the next vital signs measurement for each patient and provide highly 
visible, up-to-date reminders that observations are due.20 The EPSS warns of attempts to 
enter out-of-range data or erroneous values. It consistently assigns vital sign parameters to the 
correct EWS weightings; automatically and accurately calculates an EWS value; and 
instantly displays the EWS on the handheld devices at the bedside.20 Direct bedside entry of 
the vital signs dataset makes it quicker for staff to enter the information into patients’ records 
than with manual methods.15,16 The decision support provided by the EPSS to bedside staff is 
both instantaneous following the input of vital signs data and explicit about the desired 
escalation protocol (e.g., increase monitoring frequency, or involve RRT or critical care 
staff).20 Finally, the EPSS makes the raw data and the vital signs charts instantaneously 
available across the whole hospital via wireless PC tablets or desktop PCs, thereby enabling 
rapid spread of the time-critical knowledge of a change in a patient’s clinical condition to 
clinical teams involved in the patient’s care.20 Given that errors and failure in the processes 
involved in vital signs collection, charting and escalation have been implicated in the failure 
to recognize, or respond to, patient deterioration, it is intuitive that improving these processes 
might reduce adverse patient outcomes.  
 
Acute care educational programmes for ward staff,22 paper-based EWS systems23 and RRTs21 
were already in place in both hospitals before implementation of the EPSS. These are 
essential components of the five-ring ‘Chain of Prevention’6 (i.e., Education; Monitoring; 
Recognition; Call for help; Response), which is thought to be necessary for early detection 
and response to patient deterioration. By design, the EPSS improved the monitoring of 
patients’ vital signs, facilitated better recognition of deterioration and increased the likelihood 
that ward staff would call for help from senior clinicians and/or the RRT. Therefore, the 
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addition of the EPSS to the existing rapid response system structures is likely to have 
‘strengthened’ the ‘Chain of Prevention’6, making deterioration, and death, less likely. 
 
Finally, other research into technological solutions to improve the recognition of, and 
response to, patient deterioration has been limited to small-scale implementations, studies in 
specific patient groups (e.g., patients receiving RRT calls) or focuses on process measures.40-
51 Although many of these studies suggest potential benefit, ours is the first to consider a two-
centre, whole hospital implementation and to measure mortality in all major adult specialties. 
Our findings suggest that implementation of technology specifically designed to improve the 
processes around the recognition of, and response to, patient deterioration can change both 
process and patient outcomes. The similarity of the impact in all three main specialties in two 
unconnected hospitals  ~240 kilometres apart provides support to this being a ‘cause and 
effect’ relationship, but prospective studies are needed to confirm these results. 
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ABBREVIATION KEY 
 
EPSS Electronic physiological surveillance system 
EWS Early warning score 
IT Information technology 
QAH Queen Alexandra Hospital 
TLC The Learning Clinic Ltd 
NICE National Institute for Health and Care Excellence 
UHC University Hospital Coventry 
RRT Rapid response team 
AMU Acute Medicine Unit 
SAU Surgical Assessment Unit 
T&O Trauma and orthopaedic 
WTE Whole time equivalent 
EAU Emergency admissions unit 
NHS National Health Service 
ucl Upper control limits 
lcl Lower control limits 
SA-MR Seasonally adjusted mortality rate 
O Observed deaths 
MR Crude mortality rate 
CI Confidence intervals 
E Expected deaths 
PHT Portsmouth Hospitals `Trust 
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LEGENDS FOR FIGURES 
 
Figure 1: p-chart with control limits of +3 standard deviations of seasonally adjusted mortality rate (SA-MR) at QAH 
(Figure 1a) and UHC (Figure 1b). Observations recorded by EPSS implementation are superimposed. [ucl = upper 
control limit; lcl = lower control limit.] 
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Figure 2: Average patient age and percentage of emergency admissions during the EPSS implementation period 
shown with seasonally adjusted mortality rate (SA-MR) at QAH (Figure 2a) and UHC (Figure 2b). 
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Figure 3: CUSUM charts of cumulative monthly difference between expected and seasonally adjusted observed 
deaths (E-O) in three specialties (Medicine, 3a; Surgery, 3b; T&O, 3c) at QAH. Control limits added using the 
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method described by Grunkemeier et al.28 ‘T’ denotes deployment of the EPSS to the Acute Medicine Unit (AMU). 
‘U’ denotes implementation to the first medical ward outside the AMU. ‘V’ denotes sequential hospital-wide 
deployment, beginning with three medical wards. ‘W’ denotes opening of new hospital wing. ‘X’ denotes deployment 
to the Surgical Assessment Unit. 
 
Figure 4: CUSUM charts of cumulative monthly difference between expected and seasonally adjusted observed 
deaths (E-O) in three specialties (Medicine, 4a; Surgery, 4b; T&O, 4c) at UHC. Control limits added using the 
method described by Grunkemeier et al.28 ‘Y’ denotes sequential deployment of the EPSS to adult inpatient wards. 
‘Z’ denotes deployment to the Emergency Admissions Unit. 
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